The new ruthenium(II)-bipyridyl complex with O,O'-diethyl-(S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoate: Synthesis and characterization
Keywords:ruthenium(II) complexes, edda-type ligand, photodynamic therapy
The new bipyridyl complex of ruthenium(II) with O,O'-diethyl-(S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoate was synthesized. The reaction of cis-[RuCl2(bpy)2] and ligand was performed in water/ethanol solution, in the presence of lithium hydroxide, under reflux. The addition of ammonium hexafluorophosphate, complex was precipitated. The complex, cis-[Ru(bpy)2L](PF6)2, was characterized by 1H and 13C NMR, UV-Vis, IR spectroscopy, ESI-MS spectrometry and elemental analysis. Results indicate an octahedral geometry of the complex, with N,N'-coordinated O,O'-diethyl-(S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoate. Complexes of this type are particularly important in terms of potential cytotoxicity and application in photodynamic therapy. Using this therapy, many side effects can be reduced and this may allow administration of higher dosages drugs.
Z. Guo, P. J. Sadler, Medicinal Inorganic Chemistry, Adv. Inorg. Chem., 49, 183-306 (2000).
M.A. Jakupec, M. Galanski, V.B. Arion, C.G. Hartinger, B.K. Keppler, Antitumor metal compounds: more than theme and variations, Dalton Trans. 183-194 (2007).
M. Galanski, M. J. Jakupec, B. K. Keppler, Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches, Curr. Med. Chem., 18, 2075-2094 (2005).
R. Margalit, H. B. Gray, M. J. Clarke, L. Podbielski, Chemical and biological properties of pentaammineruthenium-bleomycin complexes, Chem.-Biol. Interact., 59, 231-245 (1986).
G. Y. Park, J. J. Wilson, Y. Song, S. J. Lippard, Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile, P. Natl. Acad. Sci. USA, 109, 11987-11992 (2012).
A. Bergamo, G. Sava, Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs, Dalton Trans., 40, 7817-7823 (2011).
K. Du, J. Q. Wang, J. F. Kou, G. Y. Li, L. L. Wang, H. Chao, L. N. Ji, Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes, Eur. J. Med. Chem., 46, 1056-1065 (2011).
L. Salassa, Polypyridyl Metal Complexes with Biological Activity, Eur. J. Inorg. Chem. 32, 4931-4947 (2011).
C. M. Allen, W. M. Sharman, J. E. V. Lier, Current status of phthalocyanines in the photodynamic therapy of cancer, J. Porphyr. Phthalocya., 5, 161-169 (2001).
R. E. Cuenca, R. R. Allison, C. Sibata, G. H. Downie, Breast cancer with chest wall progression: treatment with photodynamic therapy, Ann. Surg. Oncol., 11, 322-327 (2004).
Z. Lin, W. Shaohua, G. Xuefeng, Z. Jiahong, Y. Boyang, S. Jian, External heavy-atomic construction of photosensitizer nanoparticles for enhanced in vitro photodynamic therapy of cancer, J. Phys. Chem. B., 116, 12744-12749 (2012).
S. K. Pushpan, S. Venkatraman, V. G. Anand, J. Sankar, D. Parmeswaran, S. Ganesan, T. K. Chandrashekr, Porphyrins in photodynamic therapy-a search for ideal photosensitizers, Curr. Med. Chem.-Anti-CancerAgents, 2, 187-207 (2002).
J. Wang, S. L. H. Higgins, B. S. J. Winkel, K. J. Brewer, A new Os,Rh bimetallic with O2 independent DNA cleavage and DNA photobinding with red therapeutic light excitation, Chem. Commun., 47, 9786-9788 (2011).
M. Kang, H. T. Chifotides,K. R. Dunbar, 2D NMR study of the DNA duplex d(CTCTC*A*ACTTCC).d(GGAAGTTGAGAG) cross-linked by the antitumor-active dirhodium(II,II) unit at the cytosine-adenine step, Biochemistry, 47, 2265-2276 (2008).
L. Yao, R. Hammitt, D. A. Lutterman, L. E. Joyce, R. P. Thummel, C. Turro, Ru(II) Complexes of New Tridentate Ligands: Unexpected High Yield of Sensitized 1O2, Inorg. Chem., 48, 375-385 (2009).
E. Corral, A. C. Hotze, A. Magistrato, J. Reedijk, Interaction between the DNA model base 9-ethylguanine and a group of ruthenium polypyridyl complexes: kinetics and conformational temperature dependence, Inorg. Chem., 46, 6715-6722 (2007).
K. Karidi, A. Garoufis, N. Hadjiliadis, M. Lutz, A. L. Spek, J. Reedijk, Synthesis, characterization, and DNA-binding studies of nitro(oligopyridine)ruthenium(II) complexes, Inorg. Chem. 45, 10282-10292 (2006).
D. A. Lutterman, P. K. Fu, C. Turro, cis-[Rh2(µ-O2CCH3)2(CH3CN)6]2+ as a photoactivated cisplatin analog, J. Amer. Chem. Soc., 128, 738-739 (2006).
S. J. Chaberek, A. E. Martell, Stability of metal chelates. IV. N,N'-Ethylenediaminediacetic acid and N,N'-ethylenediaminediacetic-N,N'-dipropionic acid, J. Am. Chem. Soc., 74, 6228-6231 (1952).
J. M. Lazić, Lj. Vučićević, S. Grgurić-Šipka, K. Janjetović, G. N. Kaludjerović, M. Misirkić, M. Gruden-Pavlović, D. Popadić, R. Paschke, V. Trajković, T. J. Sabo, Synthesis and in vitro Anticancer Activity of Octahedral Platinum(IV) Complexes with Cyclohexyl-Functionalized Ethylenediamine-N,N'-Diacetate-Type Ligands, ChemMedChem., 5, 881-889 (2010).
B. P. Sullivan, D. J. Salmon, T. J. Meyer, Mixed phosphine 2,2'-bipyridine complexes of ruthenium, Inorg. Chem., 17, 3334-3341 (1978).
D. Mishra, S. Naskar, M. G. B. Drew, S. K. Chattopadhyah, Synthesis, spectroscopic and redox properties of some ruthenium(II) thiosemicarbazone complexes: Structural description of four of these complexes, Inorg. Chim. Acta, 359, 585-592 (2006).
How to Cite
The authors agree to the following licence: Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- for any purpose, even commercially.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.